key: cord-0850438-b6tnf328
authors: Xie, Peifang; Fang, Yue; Shen, Zhili; Shao, Yulan; Ma, Qinhai; Yang, Zifeng; Zhao, Jincun; Li, Hongmei; Li, Rongtao; Dong, Shuwei; Wen, Weibo; Xia, Xueshan
title: Broad antiviral and anti-inflammatory activity of Qingwenjiere Mixture against SARS-CoV-2 and other human coronavirus infections
date: 2021-10-18
journal: Phytomedicine
DOI: 10.1016/j.phymed.2021.153808
sha: 876754f5098fdca11380e1d15209046235cc87f2
doc_id: 850438
cord_uid: b6tnf328

BACKGROUND: Qingwenjiere Mixture (QJM) is a traditional Chinese medicine (TCM) that has been shown to have remarkable clinical efficacy against COVID-19. However, little is known about the antiviral and anti-inflammatory activities of QJM against a wider range of HCoV strains. PURPOSE: The study aims to investigate the antiviral and anti-inflammatory activities of QJM, as well as the underlying mechanisms against human coronavirus (HCoV) infections. METHODS: The chemical compositions from QJM were analyzed by LC-MS. The inhibitory effect of QJM on infections of HCoV-OC43, HCoV-229E, HCoV-NL63, and SARS-CoV-2 was evaluated in HRT-18 cells, Huh7 cells, LLC-MK2 cells, and Vero-E6 cells, respectively, by using cytopathic effect (CPE) inhibition assay or RT-qPCR detection of viral n, s, or RdRp/Hel genes. The expression of pro-inflammatory cytokines induced by HCoV-OC43, HCoV-229E, and SARS-CoV-2, as well as the host ace2 gene was also determined by RT-qPCR assay. Furthermore, the expression of key molecules in the NF-κB/MAPKs signaling pathways was determined by western blot. RESULTS: In alcohol-extraction groups of QJM and reference decoction pieces, 53 similar ion peaks were identified, the majority of which were phenylpropanoids, iridoids, and flavonoids. In addition, QJM reduced CPE caused by HCoVs and the expression of viral n genes or N protein. Pretreatment with QJM also exerted inhibitory effect on viral n gene expression. QJM also inhibited the expression of RdRp/Hel and s genes of SARS-CoV-2, as well as the host ace2 gene. Besides, QJM markedly reduced virus-induced mRNA expression of a panel of pro-inflammatory cytokines, such as IL-6, CXCL-8/IL-8, CXCL-10/IP-10, CCL-5/RANTES, TNF-α, IFN-α, CCL-2/MCP-1, CXCL-9/MIG, and IL1-α. We further showed that QJM inhibited the phosphorylation of NF-κB p65, and JNK, ERK 1/2, and p38 MAPKs in HCoV-OC43-infected HRT-18 cells. CONCLUSIONS: QJM has broad antiviral and anti-inflammatory activity against both common and newly emerged HCoVs possibly by inhibiting the activation of key components in NF-κB/MAPKs signaling pathway. QJM also has a prevention effect against HCoV infections and inhibits the host receptor required for virus entry. These results indicate that QJM may have the therapeutic potential in the treatment of diseases caused by a broad range of HCoVs.

Human coronaviruses (HCoVs) are single-stranded, positive-sense, enveloped RNA viruses that belong to the family Coronaviridae. There are seven strains of coronaviruses (HCoVs) that are known to infect humans. Among them, severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and currently circulating SARS-CoV-2 that caused coronavirus disease 2019 (COVID-19) are highly pathogenic Betacoronavirus and can cause acute respiratory distress syndrome (ARDS), cytokine storms, and even death worldwide. The other common HCoVs which include two Betacoronaviruses (HCoV-OC43 and HCoV-HKU1) and two Alphacoronaviruses (HCoV-229E

and HCoV-NL63), do not frequently cause severe disease, but they are related to high rate of morbidity and mortality in young children and elderly people (Brown et al., 2019; Hui et al., 2014; Tian et al., 2020) . The common HCoVs and newly emerging HCoVs share a similar life cycle, but their genomic sequences and pathogenicity are different. Unfortunately, vaccines and pharmacological treatment for HCoV infections are still limited, and symptomatic relief and complication prevention remain the most important management strategy (Zumla et al., 2016) .

Given the threats posed by circulating and emerging viruses, it is urgent to explore medicines with a broad spectrum of antiviral drugs that target a range of HCoVs. Antiviral agents, particularly those that target RNA viruses, have been repurposed for antiviral therapy against COVID-19. Several drugs, such as remdesivir (RDV), favipiravir, chloroquine, and arbidol (ARB), efficiently inhibited viral replication in SARS-CoV-2-infected Vero E6 cells and RDV was even considered as the antiviral hope against SARS-CoV-2, however, clinical trials was required to further evaluate the efficacy and safety of these drugs (Lam et al., 2020) . Traditional Chinese medicine (TCM) has a long history of clinical use in the treatment of infections caused by respiratory viruses. During the last year, TCM has been widely used (almost 85%) for the treatment of COVID-19 patients in China . For example, a Chinese patent medicine, Lianhuaqingwen capsule (LH), has been shown to reduce the time to recovery of fever and cough in patients infected with SARS-CoV-2 (Hu et al., 2021) . Qingfei paidu decoction (QPD) is a another TCM prescription that has been demonstrated to significantly shorten symptom recovery time and increase cure rates without causing adverse effects in over 100 patients infected with SARS-CoV-2 .

Qingwenjiere Mixture (QJM) is a TCM formula that is developed based on the theory of prevention and cure of "plague". The main ingredients of this formula are usually prescribed for the treatment of flu-like symptoms, asthma, inflammation, tonsillitis, and sore throat (Lin et al., 2020) . Indeed, QJM is effective in reducing fever, sore throat, and cough, as well as decreasing the levels of C-reactive protein (CRP) and hypersensitive C-reactive protein in patient with flulike symptom (unpublished) . During the COVID-19 outbreak, QJM was used in designated hospitals in Yunnan and Hubei Provinces, as well as neighboring countries such as Laos and Myanmar, and demonstrated remarkable clinical efficacy in SARS-CoV-2-infected patients, including reducing CRP level in serum, improving the absorption of pulmonary inflammation, and shortening the length of hospital stay (unpublished). A network pharmacological analysis of QJM has identified 32 putative targets against COVID-19, which were retrieved from both the OMIM and Gene cards data C databases . These findings indicated that QJM may be effective against HCoV by alleviating the inflammatory responses.

Infections with HCoVs may result in inflammatory responses that promote viral replication and cause respiratory tissue injury. For example, HCoV infections activated NF-κB signaling pathway by depredating IκBα and promoting p65 chromatin recruitment, and thereby allowed the synthesis of A20 protein (TNFAIP3) essential for effective viral replication (Poppe et al., 2017) .

Additionally, the generation of dsRNA activated the NF-κB/MAPK pathways, resulting in the production of substantial amounts of pro-inflammatory cytokines, such as CCL-2/MCP-1, IL-10, and CXCL-10/IP-10, which may cause lung tissue damage, edema, and even ARDS (Kono et al., 2008) . Furthermore, it has been demonstrated that the MAPK signaling pathway is involved in the development of SARS-CoV-related lung fibrosis (Li et al., 2016) . It remains unclear whether QJM could interfere with these pathways, hence inhibiting HCoV replication and excessive proinflammatory responses. In this study, we aimed to explore the antiviral and anti-inflammatory effects of QJM against common and newly emerging HCoVs. We also investigated the possible mechanism for the anti-viral and anti-cytokine activities of QJM.

The effects of QJM on various HCoVs were compared with LH, ARB, and RDV. The ingredients of QJM were shown in Table1. The powdered raw materials of LH was provided by the Institute of Chinese Materia Medica, China Academy of Chinese medical sciences. ARB tablets (0.1g per tablet) were purchased from CSPC Ouyi Pharmaceutical Co., Ltd, and RDV was provided by Prof. Zifeng Yang from Guangzhou Medical University. For the preparation of drug stock solution, QJM was dissolved in phosphate-buffered saline (PBS) to a concentration of 600 mg/mL, and RDV, LH and ARB, were dissolved in dimethyl sulfoxide (DMSO) to concentrations of 100 mM, 300 and 100 mg/mL, respectively. These solutions were stored at -20°C before use. were provided by Chinese medicine hospitals in Yunnan Province, and were respectively extracted with 95% aq. EtOH (3 times) at room temperature for 24 h each time. The filtrate was subsequently concentrated under vacuum to yield a crude extract. An appropriate amount of crude extract was dissolved in water or MeOH and filtered before being analyzed by using a liquid chromatograph-mass spectrometer (LC-MS). The ion peaks (or quasi-molecular ion peaks) with the same retention time (tR) and mass-to-charge ratio (m/z) in QJM and a certain decoction piece were identified. Then, the possible chemical composition of the ion peaks was determined by reviewing the literature and compared with the reference decoction pieces.

The The cytopathic effect (CPE) was then recorded, and the 50% tissue culture infective dose (TCID 50 ) was calculated by using the Reed-Muench method. Viral stocks were stored at -80°C.

SARS-CoV-2 infection was conducted in biosafety level-3 (BSL-3) laboratory, while other infections were carried out in BSL-2 laboratory.

The cytotoxic effects of drugs on HRT-18, Huh-7, LLC-MK2, and Vero E6 cells were measured by methyl thiazolyl tetrazolium (MTT) assay. Briefly, cell monolayer grown in 96-well plates was incubated with indicated concentrations of drugs. After 48 h, the cells were stained with MTT solution at 1 mg/mL at 37℃ for 4 h. The supernatants were then discarded, and 150 μL dimethyl sulfoxide (DMSO) was added the each well to dissolve formed formazan crystals in cells. The absorbance at 490 nm was measured by using a Multiskan GO Microplate Spectrophotometer (Thermo Fisher, USA). The 50% cytotoxic concentration (CC 50 ) of drugs to cells was calculated by the GraphPad Prism 8.0 software.

The cell monolayer grown in 96-well plates was inoculated with 100 TCID 50 of HCoVs at 34°C for 2 h. After removing the inoculums, cells were treated with indicated concentrations of drugs in culture medium with 2%FBS at 34°C in a 5%CO 2 incubator. The treatment period was 3 days for HCoV-229E and SARS-CoV-2, and 5 days for HCoV-OC43. At the end of the treatment, the percentage of CPE was recorded, and the 50% inhibitory concentration (IC 50 ) of agents against CPE was then calculated by using the Reed-Muench method.

For pretreatment experiment, confluent monolayer of Huh7 and HRT-18 cells grown in 12well plates was incubated with the medium containing QJM at 2000, 1000, 500, and 250 μg/mL for 0, 2, and 6 h, which was followed by the infection with HCoV-229E and HCoV-OC43, respectively, at a multiplicity of infection (MOI) of 1. After adsorption at 34℃ for 2 h , the cells were rinsed twice with PBS and incubated with drug-containing culture medium. The supernatants of Huh7 and HRT-18 cells were collected at 72 and 120 hours post infection (hpi), respectively, and the copy numbers of viral genes were determined by RT-qPCR assay.

For treatment experiment, confluent monolayer of HRT-18, Huh7, LLC-MK2 and Vero E6 cells was infected with HCoV-OC43, HCoV-229E, HCoV-NL63 or SARS-CoV-2 at a multiplicity of infection (MOI) of 1. After adsorption at 34℃ for 2 h, the virus inoculum was removed, and HRT-18 and Huh7 cells were incubated with culture medium containing the same concentration range of drugs as the pretreatment process, while LLC-MK2 cells and Vero E6 cells were incubated with the medium containing QJM at 1000, 500, 250 and 125 μg/mL. The supernatants of Vero E6, Huh7, and HRT-18 cells were collected at 48, 72, and 120hpi, respectively, while the supernatant of LLC-MK2 was collected at 7 days post infection (dpi). The copy numbers of viral genes from supernatants were detected by RT-qPCR assay. Also, the cell layer was harvested for RNA isolation and subsequent determination of cytokine and ace2 gene expression.

For quantification of viral genes, total viral RNA was isolated from the supernatant with the E.Z.N.A. viral RNA extraction R6874-02 kit (Omega Bio-Tek, USA) according to manufacture instructions, and RT-qPCR was performed with One Step PrimeScript™ RT-PCR Kit (Perfect Real Time) (Takara Bio, Japan). The nucleoprotein (n) genes of HCoV-OC43, HCoV-229E, and HCoV-NL63 were cloned into pEASY-T1 cloning vector (TransGen Biotech, China), and the RdRp/Hel gene of SARS-CoV-2 was cloned into pTRIPLEscript vector (Ambion, USA). The standard curves of plasmids were subsequently generated for evaluation of copy numbers of HCoVs genome (Chan et al., 2020) .

For quantification of mRNA levels of cytokines, ace2 and s genes, total RNA was isolated from cells with an RNAiso Plus reagent (Takara Biotechnology, China) according to the manufacturer's protocol, and the reverse transcription was performed with PrimeScript™ RT Master Mix Kit (Perfect Real Time) (Takara Bio, Japan). The expression levels of proinflammatory cytokines and ace2 gene were detected by RT-qPCR with the Premix Ex Tap™ (Probe qPCR) or SYBR Premix Ex Tap™ II (Takara Bio, Japan) and calculated by using the 2 −ΔΔCt method with GAPDH as an internal reference gene. The qPCR was conducted with an ABI detection system (ABI PRISM® 7500 Real-time PCR system, Applied Biosystems Co., USA).

The primer sequences for quantitative measurement of HCoVs n, RdRp/Hel genes and cytokines/chemokines were shown in supplementary table 1.

HRT-18 cells were seeded into 6-well plates at a density of 2 x 10 5 cell/well. After growing into monolayer, the cells were infected with HCoV-OC43 (MOI =1) for 2 h. The inoculums were removed, and cells were treated with different concentrations of QJM. At 96 hpi, total protein was extracted for western blot analysis as mentioned in our previous study with the modification of using 10% SDS-PAGE and PVDF membranes (0.2 μm, Bio-Rad, USA) (Dong et al., 2019) .

Membranes were incubated overnight at 4°C with antibodies against P-Ser536-NF-kB p65, p65, P-ERK1/2, ERK1/2, P-p38, p38, P-SAPK/JNK, SAPK/JNK, GAPDH (Cell Signaling, USA), HCoV-OC43 (Millipore, USA, MAB9012), followed by an HRP-conjugated secondary antibody.

The immunocomplexes were detected using enhanced chemiluminescence (ECL, Amersham, USA) and quantified by Image J software.

Statistical analyses were performed using one-way analysis of variance (ANOVA) (IBM SPSS statistics 21.0, USA). All results were the representative or the average data from at least 3 independent experiments. All the numerical results were presented as mean ± standard error of the mean (SEM). Significance was considered when P< 0.05.

To better understand the chemical composition of QJM, samples of QJM were analyzed by UPLC fingerprints. The water-and alcohol-extraction groups of the powdered QJM and 8 compatible decoction pieces were analyzed by LC-MS. When the retention time and ion flow data were combined, few ion peaks were yielded from the water-extraction group, while 53 common ion peaks were identified in the alcohol-extraction group of QJM powder and the reference decoction pieces ( Fig. 1 

The antiviral effects of QJM against HCoVs were investigated and compared to that of LH and ARB. LH and ARB were both effective against influenza virus infection, and recent studies showed that these two drugs could inhibit SARS-CoV-2 replication (Nojomi et al., 2020; . In this study, the cytotoxicity of these drugs was firstly determined by MTT assay, and the CC 50 value of QJM in HRT-18, Huh7, and LLC-MK2 cells was 12179.12±74.17, 6534.38±74.04, and 11617.78±43.39 μg/mL, respectively ( Table 2 ). The infections of HCoV-OC43 and HCoV-229E induced obvious CPE, which was inhibited by QJM treatment with IC 50 values of 298.34±8.69 and 54.04±4.23 μg/mL, respectively. QJM appeared to be more effective than LH in inhibiting these two viruses, as evidenced by lower IC 50 values (Table 2 ). In addition, ARB was effective against HCoV-OC43 but not against HCoV-229E (Table 2 ). The IC 50 values of QJM and LH against HCoV-NL63 at 7dpi were 118.07±3.60 and 354.37±29.20 μg/mL, respectively (Table 2) . However, ARB was ineffective in inhibiting the n gene of this virus.

Furthermore, QJM showed higher SI values than LH and ARB, which suggests that QJM maybe more effective and safer in the treatment of HCoVs (Table 2) .

We further investigated the influence of QJM on the expression of mRNA or protein of an HCoV-OC43 at 72 hpi, and the inhibition decreased at the following time points (Fig. 2Aa, b) .

Furthermore, QJM, LH, and ARB significantly reduced the expression level of N protein of HCoV-OC43 detected by western blot assay (Fig. 2Ac) . These results indicated that QJM inhibited common HCoV replication at nucleic acid or protein level.

Given that many Chinese medicines were more effective when used prophylactically (Xu et al., 2012) , we next evaluated the inhibitory effect of QJM pretreatment on the viral n gene expression. The drugs were added to cells at 6, 2, and 0h prior to infection, as well as 2h following virus incubation, and the viral n gene was detected at 120hpi (HCoV-OC43) or 72hpi (HCoV-229E). The results showed that LH, ARB, and QJM effectively inhibited the viral gene when added to cells at all time points before viral infection (Fig.2B) . Interestingly, the inhibition rate of QJM was significantly higher in the pretreatment assay than in the treatment assay ( Fig.2B ).

Besides common HCoVs, the effects of QJM against the newly emerging SARS-CoV-2 were further investigated and compared to those of LH, ARB, and RDV (Nojomi et al., 2020; Sreekanth Reddy and Lai, 2021; Yang et al., 2020) . Despite less effective in inhibiting SARS-CoV-2-induced CPE, QJM had a higher SI value than LH and ARB (Table 2 ). QJM could also significantly inhibit the expression of viral RdRp/Helicase gene in supernatant of infected cells (Fig. 2Ca) . It was reported that the entry process of SARS-CoV-2 was mediated by the binding of envelope-embedded surface-located spike (S) glycoprotein to the entry receptor ACE2 from humans and other species (Lu et al., 2015) . We therefore investigated the effect of QJM on both viral s and host ace2 genes by using RT-qPCR assay. The results showed that QJM was more potent than RDV, LH, and ARB in inhibiting the mR286NA expression levels of these two genes (P<0.05, P<0.01, P<0.001) (Fig. 2Cb, c) . These results indicated that QJM was effective in suppressing not only the viral gene but also the host factor associated with SARS-CoV-2 infection.

Aberrant immune responses characterized by excessive production of pro-inflammatory mediators and increased recruitment of immunocytes could accelerate the disease progress of HCoV infections (Totura and Baric, 2012; Yamaya et al., 2020) . Therefore, we investigated whether QJM has the inhibitory effect on the production of pro-inflammatory mediators in HCoV-infected cells. As shown in Fig. 3A and 3B, infection with HCoV-OC43 and HCoV-229E dramatically increased the mRNA levels of IL-6, TNF-α, CXCL-8/IL-8, IFN-α, CCL-2/MCP-1, and CXCL-9/MIG, while QJM treatment exhibited different degree of inhibition on the expression of these cytokines and chemokines in a dose-dependent manner (P<0.001).

Furthermore, 500 μg/mL of QJM was more effective than ARB in reducing levels of CXCL-8/IL-8 and CXCL-9/MIG and was also superior to LH in suppressing the level of CXCL-8/IL-8 (P<0.001) in HCoV-OC43-infected cells (Fig. 3Ac, h) . In HCoV-229E-infected cells, QJM at high concentration (1000 μg/mL) had the anti-inflammatory effect comparable to LH, while QJM at low concentration (250 μg/mL) was generally less effective than LH but better than ARB (Fig. 3B) .

Moreover, the mRNA levels of IL-1α and CCL-5/RANTES were significantly upregulated at 48 hpi in Vero E6 cells infected with SARS-CoV-2 (P<0.001), which was remarkably reduced to varying degrees by the treatment of QJM, LH, ARB, or RDV (P<0.001) (Fig. 3C) .

Furthermore, QJM at 500 or 250 μg/mL was more effective than RDV and LH in reducing the level of IL-1α (P <0.05, P<0.001) (Fig. 3Ca) , and QJM at 250 μg/mL also showed superior inhibition on the expression of CCL-5/RANTES as compared with LH (P<0.001) (Fig. 3C) .

These results indicate that QJM could have the potential to attenuate HCoV-induced proinflammatory responses.

HCoV infections can trigger the activation of diverse cellular signaling pathways, such as the canonical NF-κB pathway and MAPK pathway, which regulates the downstream production of pro-inflammatory cytokines (De Wilde et al., 2018) . Given that QJM potentially inhibited the production of multiple cytokines, we next examined whether the anti-cytokine activity of QJM was related to its impact on the expression of key components in cellular pathways. As expected, infection with HCoV-OC43 for 96h resulted in significant phosphorylation of p38, NF-κB p65, SAPK/JNK, and ERK 1/2 in HRT-18 cells, which was markedly inhibited by the treatment of QJM, LH, or ARB (P<0.05, P<0.001) (Fig. 4A, B ). In addition, QJM was more effective or had a broader range of effective concentrations in inhibiting P-p38 and P-p65 than P-SAPK/JNK and P-ERK1/2 (Fig. 4B) . These results indicate that QJM inhibits the cytokine production possibly by interrupting with the activation of NF-kB p65 and p38/ERK/JNK MAPK signaling pathways induced by HCoV-OC43.

The ongoing outbreak of COVID-19 has made clear that efficient remedies for lifethreatening coronavirus infections are definitely lacking. TCM has been proved to be effective against newly emerged HCoV outbreaks. However, previous studies mainly focused on the effect of TCM in treating specific HCoV strain, and our understanding of the antiviral mechanism remains limited (Abd El-Aziz and Stockand, 2020; Cai and Gu, 2020) . In this study, we showed that QJM treatment inhibited the viral load of various HCoV strain in vitro. Interestingly, pretreating cells with QJM resulted in higher inhibition rates on virus titer than treating cells after virus incubation. These results partially support a role for QJM in preventing the entry of HCoVs into the host. It has been shown that the entry of HCoVs was facilitated by the binding of S protein to host receptors, which determined the virus tissue tropism (Petersen et al., 2014; De Wilde et al., 2018) . The inhibition of SARS-CoV-2 s gene and host ace2 gene suggests that QJM may target not only the viral gene but also target the host factor required for HCoV entry.

In previous studies, TCMs such as LH, QPD, Xuebijing injection, Jinhua Qinggan granules presented remarkable effects in clinical treatment of COVID-19, and network pharmacology analysis revealed that the active ingredients of these drugs could directly act on viral proteins and exhibit anti-inflammatory and immunoregulatory effects against HCoVs infection (Huang et al., 2020) . QJM is a formula composed of 13 decoction pieces with intricate chemical composition.

According to the TCM theory, the benefits of the combination of these herbs include clearing damp-heat, lifting up yang qi, reducing toxicity, eliminating phlegm, and so on (Table 1) . In this study, we identified 132 potential chemical compounds in QJM and 8 reference decoction pieces by using LC-MS analysis, with phenylpropanoids, iridoids, and flavonoids being the 3 most common constituents. Chlorogenic acid is a phenylpropanoid that has been identified in Chaihu (Bupleurum chinense DC.) and Yinchen (Artemisia capillaris Thunb.) of QJM. Chlorogenic acid has been reported to be the main active ingredient in Xuebijing injection and was believed to have an anti-inflammatory effect against SARS-CoV-2 (He et al., 2020) . However, the effects of iridoids on HCoV infection were barely reported (Gong et al. 2008 ). In addition, flavonoids extracted from many herbs were capable of inhibiting the replication of HCoVs (Gong et al. 2008 ). In our study, flavonoids were the main chemical components from Chaihu (Bupleurum chinense DC.) and Huangqin (Scutellariae baicalensis Georgi.). The quercetin, a flavonoid identified in Chaihu (Bupleurum chinense DC.) of QJM, was the active compound in LH, QPD, Xuebijing injection, and Jinhua Qinggan granules, and has been suggested to have antiviral and anti-inflammatory properties against infection with SARS, MERS, and SARS-CoV-2 (Huang et al., 2020b) . In addition, we identified another flavonoid, isorhamnetin, in Chaihu (Bupleurum chinense DC.) of QJM, and this chemical compound has been previously isolated from QPD and exhibited anti-cytokine activity (Xu et al., 2020) . In the present study, 8 steroids were identified in decoction pieces of QJM, including Baiwei (Cynanchum atratum Bunge.), matixiang (Valeriana jatamansi Jones), and lianqiao (Forsythia suspensa (Thunb.) Vahl.). We also identified a phenolic compound, tachioside, in chaohoupu (the processed bark of Magnolia officinalis Rehd. et Wils. var. biloba Rehd. et Wils.) . It has been shown that herb-derived phenolic compounds had inhibitory effect on SARS-3CL pro activity (Lin et al., 2005) . In general, the antiviral and anti-inflammatory activities of QJM was in line with the pharmacological activities of these chemical constituents identified in decoction pieces, which may provide a better understanding of the effect and mechanism of QJM in the treatment of HCoV infection.

The infection with HCoV could result in overproduction of cytokines and chemokines, which contributes to the disease severity. Patients with SARS-CoV-2 infection who required ICU admission had higher concentrations of CSF3/G-CSF, CXCL-10/IP-10, CCL-2/MCP-1, CCL-3/MIP-1α, and TNF-α than non-ICU patients (Huang et al., 2020) . In a previous study, network pharmacological analysis identified 32 potential targets between QJM and COVID-19, including IL-6, TNF, and CCL-2/MCP-1, which was consistent with our finding that QJM suppressed the mRNA expression of these cytokines . It has also been reported that disruption of the CCL5-CCR5 axis could have the potential to reduce inflammation and viral load in terminally-ill, critical COVID-19 patients (Patterson et al., 2020) . In the present study, QJM significantly reduced the mRNA expression of CCL-5/RANTES in SARS-CoV-2-infected Vero E6 cells, indicating that it may restore the immunologic dysfunction and reduce viral burden in COVID-19 patients. Besides, suppressing IL-1 released by damaged epithelial and endothelial cells in response to SARS-CoV-2 infection has been suggested another host-directed therapy for COVID-19 (Van de Veerdonk and Netea, 2020) . The reduction of IL-1α expression by QJM may add to our understanding of its anti-inflammatory activity in the treatment of COVID-19.

Cellular signaling cascades are involved in the network of virus-host interaction and act as a double-edged sword. The activation of NF-κB and/or MAPKs signaling pathways could result in the production of pro-inflammatory cytokines such as CCL-2/MCP-1, CXCL-10/IP-10, IFN-α and CXCL-8/IL-8, which further recruited white blood cells to defeat viral infection (Bonizzi and Karin, 2004; Mubarak and Alturaiki, 2019) . However, continued activation of the signaling pathway by pro-inflammatory cytokines, as well as signaling pathway-regulated cytokine production, could intensify the feed forward loop (Bonizzi and Karin, 2004) , resulting in cytokine storm and the resultant severe tissue injury in HCoV-infected patients . Apart from their role in inflammation, prior research established that the recruitment of p65 chromatin was required for a step after N protein production, as well as the development of host A20 protein, both of which were required for efficient virus replication (Poppe et al., 2017) .

Additionally, increased expression of MAPKs pathways family members, such as p38, ERK1/2 and JNK, would promote the synthesis of viral nonstructural proteins (NSPs) protease, which could bind to N protein, tether the viral genome to the replicase-transcriptase complex (RTC), and further package the encapsidated genome into viral particles (Li et al., 2016; Mubarak and Alturaiki, 2019; Varshney and Lal, 2011; Wang et al., 2020) . It has also been demonstrated that p38 kinase facilitated the replication of HCoV-229E, Murine Coronavirus (BHV), and MERS-CoV (Hemmat et al., 2021) . Therefore, it is possible that QJM treatment may help control of cytokine storm associated with HCoV infections by inhibiting the activation of the signal cascades. On the other hand, the suppression of p38, JNK and ERK MAPKs by QJM may alter the intracellular environment, making it less favorable to viral multiplication. However, the limitation of our study is that we did not evaluate whether these putative targets contribute to the pharmacological activities of QJM. It is important to use agonists of P-p65, P-p38, P-ERK, and P-SAPK/JNK following QJM treatment to determine the antagonistic effects on the antiviral and/or anti-cytokine activity of QJM, which will allow for the validation of the molecules that QJM utilizes to inhibit viral replication or cytokine production. In general, these results provide a primary understanding of the possible mechanism of QJM against innate immune response in HCoV infections.

In conclusion, the current study demonstrates that QJM exerts a broad spectrum of antiviral and anti-inflammatory activities against both common and newly emerged HCoVs by interfering with the activation of NF-κB/MAPKs pathways. In addition, QJM has a prophylactic effect against HCoVs and inhibits the host receptor required for virus entry. All these findings may contribute to a better understanding of the clinical application of QJM. * P < 0.05, ** P < 0.01, *** P < 0.001, compared with HCoV-infected cells without drug treatment; # P < 0.05, ## P < 0.01, ### P < 0.001, compared with RDV, ARB, or LH. 

Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) -an update on the status

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase

Reacher progress of coronavirus and drugs. Chin

Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens

Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming

Characteristics and application of immune-regulating and antiviral Chinese materia medica

Host Factors in Coronavirus Replication

The Susceptibility of Primary Dermis Fibroblasts from the Chinese Tree Shrew to Human Cytomegalovirus Infection

SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro

Coronaviruses: an overview of their replication and pathogenesis

A study on anti-SARS

CoV 3CL protein of flavonoids from litchi chinensis son core

Potential Mechanism of Xuebijing Injection in Treatment of Coronavirus Pneumonia Based on Network Pharmacology and Molecular Docking

The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV

Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease

Severe acute respiratory syndrome vs. the Middle East respiratory syndrome

Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb

Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK

COVID-19: A review of the proposed pharmacological treatments

A comparative study on the law of syndrome differentiation and treatment of wet disease in Shanghan Lun and Wenbing Tiaobian

SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-β1 via ROS/p38 MAPK/STAT3 pathway

Shegan-Mahuang Decoction ameliorates asthmatic airway hyperresponsiveness by downregulating Th2/Th17 cells but upregulating CD4+FoxP3+

Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds

NF-κB p65 Knock-down inhibits TF, PAI-1 and promotes activated protein C production in lipopolysaccharide-stimulated alveolar epithelial cells type II

Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond

Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development

Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza viruses

Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial

Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral

Health-care associate transmission of Middle East Respiratory Syndrome Corona virus, MERS-CoV, in the Kingdom of Saudi Arabia

The NF-κB-dependent andindependent transcriptome and chromatin landscapes of human coronavirus 229E-infected cells

Tackling COVID-19 Using Remdesivir and Favipiravir as Therapeutic Options

Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies

SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon

Blocking IL-1 to prevent respiratory failure in COVID-19

SARS-CoV accessory protein 3b induces AP-1 transcriptional activity through activation of JNK and ERK pathways

Coronaviruses: An Updated Overview of Their Replication and Pathogenesis

Mechanism of Qingfeipaidu Decoction on COVID-19 Based on Network Pharmacology

Research the relations between the efficacy of Chinese Medicine in the prevention influenza and mucosal immune

Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells

Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective

Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2

Signal Transduction in TNF-alphainduced c-jun Gene Expression

Current understanding on antihepatocarcinoma effects of xiao chai hu tang and its constituents. Evid Based Complementary Altern Med

Mechanism Studies of Qingwen Jiere Mixture on Corona Virus Disease 2019 Based on Network Pharmacology

Coronaviruses -drug discovery and therapeutic options

Huh7/HCoV-229E 9

Huh7/HCoV-229E 9